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(Sigma Chemical Co., St. Louis, MO) in chloroform solution had a molar absorbance of 59,600 at 450 nm, so that an "unbound" bilirubin concentration of 0.058 mg/100 ml (1.0 Speculation pmol/liter) recovered from 100 p1 serum would have an optical Both Sephadex gel filtration and peroxidase oxidation tech-density of 0.006 when extracted into 1.0 ml chloroform. Biliruniques appear capable of predicting the indirect bilirubin con-bin binding capacity was estimated by plotting the optical density centration at which the first or "tight" bilirubin binding site will of recovered bilirubin against total bilirubin concentration for be saturated, and above which free bilirubin concentration will each serum aliquot, as shown in Figure 1 (upper part) . The x be greatly increased. In neonatal sera, the two methods showed intercept of a line drawn through the optical density readings close agreement for individual determinations of binding capac-obtained was designated as the saturation point (3, 13), or total ity over a wide range of molar ratios. The lower limit for the bilirubin binding capacity, of the serum. Using aliquots of the neurotoxic concentration of unbound or "free" bilirubin is not same serum, bilirubin binding capacity was also determined by precisely known and may vary in the face of multiple clinical use of the peroxidase oxidation technique described by Jacobsen factors. However, it seems likely that free bilirubin concentra-and Wennberg (8) . Aliquots of 25 pI serum were added to 1.0 tions in excess of those measured at saturation of the first ml 0.055 M sodium phosphate buffer, at pH 7.4, in matched binding site would be potentially neurotoxic, and that bilirubin semimicrocuvettes of 1.0 cm path length. Freshly made crystalbound to secondary binding sites would be more readily dissoci-line bilirubin solution (0.5 mg bilirubin in 1.0 ml 0.1 N NaOH). able.
was added to the cuvettes; each 1.0 p1 added bilirubin solution increased the bilirubin concentration of the sample by 2.0 mg/ 100 ml. Peroxidase oxidation of each patient serum was carried Estimation of serum bilirubin binding capacity in neonatal out for 7-10 increments of serum bilirubin concentration by jaundice is possible by several methods (2, 4, 8, (11) (12) (13) . Of measuring the l-min change in optical density at 460 nm these, the technique of gel filtration and column elution with following the addition of peroxidase. The reactions took place Sephadex G-25 (2-4, 13) has several advantages over dye at 24' in a Gilford model 240 spectrophotometer (Gilford binding (4, 12) or displacement (11) techniques: bilirubin itself Instrument Co., Oberlin, OH) and the optical density changes is used to determine binding capacity and the method yields an were recorded continuously on a chart recorder. By this proceestimate of binding capacity which can be expressed directly as dure, a titration curve could be obtained, as shown in Figure 1 indirect bilirubin concentration or as a molar ratio of bilirubin (lower part).
Free bilirubin concentration was calculated as
Reproducibility of the peroxidase titration method was as-
sessed by duplicate determinations in 11 patient sera; the UB (pg/100 ml) average difference between determinations of bilirubin binding ---V,, (AOD/min) capacity was 5.1 + 3.5 %, and between determinations of free K, (AOD/pmol/liter/min) bilirubin, 4.5 + 2.6% (mean + SD).
x 585 (pg/pmol) x 0.1, where UB = the unbound or free bilirubin concentration of RESULTS the sample, V, = the 1-min absorbance change during the oxidation reaction, K, = the velocity constant or rate constant for horseradish peroxidase at a final concentration of 10 pglml, and 585 = the molecular weight of bilirubin. The same lot of crystalline peroxidase enzyme (Sigma) (activity 89 purpurogallin U/mg) was used for all determinations; fresh solutions of 1.0 mg enzyme in 1.0 ml deionized distilled water were prepared and standardized weekly or twice weekly, as needed, and were stable for 5 days at 4' . An enzyme concentration of 10 pg/ml was used in the clinical determinations (i.e., 10 p1 enzyme solution were added to 1.0 ml buffer plus reagents). The rate constant, K,, for the enzyme was determined by the method of Jacobsen and Wennberg (8), using freshly prepared aqueous bilirubin solutions with no albumin. Absorbance of these solutions, recorded for 2 min, was sfable until the addition of enzyme. An average of 11 weekly determinations gave a rate constant, K,, of 3.35 Figure 1 (lower part) shows a typical titration curve on one infant's serum for the peroxidase oxidation technique. Between 7.6 and 23.6 mg/100 ml, there is a gradual increase in the rate of oxidation and in free bilirubin concentration. Between 27.6 and 43.6 mg/100 ml there is an increase in the slope of the curve, indicating an increased rate of oxidation and a more rapid increase in free bilirubin concentration. Straight lines extrapolated from the two slopes intersect at 26.2 mgllOO ml(448 pM/ liter); this concentration is the approximate limit of "tight" binding of bilirubin to albumin (i.e., binding of bilirubin to the first albumin binding site) and is considered as the bilirubin binding capacity for this sample. Bilirubin binding capacity of the same sample was 27.8 mgI100 ml (475 pM/liter) by Sephadex gel filtration (Fig. 1, upper part) . Since the serum albumin concentration is 3.8 g/100 ml (550 pM/liter), the binding capacity is 0.82 mol bilirubin bound/mol albumin by the peroxidase method and 0.86 mol bilirubin/albumin by the Sephadex method. Thirty-five comparisons of bilirubin binding capacity measured by Sephadex gel filtration and peroxidase oxidation techniques showed a high degree of correlation (r = 0.961, P < 0.001) (Fig. 2) .
Serum indirect bilirubin concentration was 11.1 a 4.6 mg/ 100 ml, (190 a 79 pM/liter), and serum albumin concentration M-I. At the saturation point, free bilirubin was 1.87 + 0.54 pg/ 100 ml (0.032 2 0.009 pM/liter) by the peroxidase method, and "unbound" bilirubin was 190 + 80 pg1100 ml(3.25 + 1.37 pM/liter) by the Sephadex method (Table 1 ). There was no correlation between free bilirubin levels determined by oxidation and those estimated by Sephadex column elution (r = 0.319, P = NS).
DISCUSSION
The close agreement obtained between Sephadex and peroxidase techniques for estimation of bilirubin binding capacity indicates that both methods are able to predict an indirect bilirubin concentration above which the free bilirubin concentration will rise rapidly. The use of Sephadex gel filtration for clinical determination of bilirubin binding capacity is therefore given some independent support by the use of a sensitive method which does not depend on competition in vitro between albumin and another binding substance (Sephadex). However, "free" bilirubin concentrations estimated by the Sephadex technique exceeded the values obtained with peroxidase by approximately 100-fold. The concentrations of "unbound" or "free" bilirubin obtained by gel filtration in the present study are similar to values for free bilirubin reported by Zamet and Chunga (IS), who also used Sephadex columns. However, no correlation was found between the free bilirubin concentrations obtained by the Sephadex and by the peroxidase techniques. In the material studied and with the methods employed, Sephadex gel filtration appears to yield reasonable estimates of bilirubin binding capacity (3, 13 ), but appears incapable of yielding reliable estimates of free bilirubin concentration. Compared to values obtained with the more sensitive peroxidase assay, the recovery of much higher concentrations of bilirubin from Sephadex columns indicates that some loosely bound as well as unbound bilirubin may be adsorbed in the column bed.
The adsorption of loosely bound as well as free bilirubin by the Sephadex column would tend to promote further dissociation of bilirubin from weaker binding sites, to maintain equilibrium between free and bound bilirubin, as the serum passes through the column. The bilirubin measured as the unbound fraction would then represent the total amount of bilirubin adsorbed, rather than the free bilirubin initially present in the serum. In the enzymatic determination, free bilirubin concentration is estimated from the initial oxidation rate, which has been shown to be proportional to the free bilirubin concentration at the start of the reaction (7, 8) .
Our findings with the peroxidase method for bilirubin binding capacity and free bilirubin concentrations in neonatal sera are similar to the results of iacobsen and Wennberg (8) (14) . Jacobsen and Wennberg showed in vitro that purified adult albumin (Cohn fraction V) had the same binding capacity (1 mol bilirubin/mol albumin) by Sephadex and peroxidase techniques of measurement (8); the present findings confirm that there is also a consistent close agreement between the two techniques for infant sera over a wide range of gestational ages and at molar ratios varying between 0.51 and 1.04 mol bilirubin bound/mol albumin.
In these studies, the difference between normal body temperature (37") and the lower temperature (24") employed for control of the reaction rate was compensated for by standardizing all components of the peroxidase reaction at the lower temperature; this correction does not preclude the possibility that equilibrium concentrations of free bilirubin in vivo and at higher temperatures might differ somewhat from those reported here. The dilution (1:40) employed to permit the use of small samples might also tend to produce an underestimate of in vivo free bilirubin concentrations by reducing the effects of weak competitors for bilirubin binding sites. Although technically more difficult, free bilirubin determinations would most nearly approximate in vivo conditions if they were performed in undiluted serum at physiologic temperature.
There was good agreement for measurements of bilirubin binding capacity between the peroxidase titration curves as described and Scatchard plots of the same data. As illustrated in Figure 1 , serial increases in free bilirubin with addition of bilirubin to the sample, as well as the similarities and differences in results between the peroxidase and Sephadex techniques, were more conveniently represented by the use of titration curves in this study.
Compared to the Sephadex column method, the working time for peroxidase titration is similar (40-45 min); single specimens can be analyzed for free bilirubin in 5-10 min. The amount of serum required for peroxidase titration (200-250 p1 for 8-10 determinations) is substantially less than for Sephadex gel filtration (100 pl/column). Although the technique of peroxidase oxidation is more complicated and requires more sophisticated equipment, the procedure is capable of yielding more information than the Sephadex method. In addition to the binding capacity of the first albumin binding site and the free bilirubin concentration, the association constant (binding affinity) of the first binding site can also be determined ( 6 , 8). Appropriate clinical interpretation of free bilirubin determinations will require further study. At present, prediction of clinical outcome based on free bilirubin measurements has not been established. The clinical utility of both methods for measurement of bilirubin binding and the applicability of our present findings to the management of individual patients should be further verified by prospective observations of long term as well as short term clinical outcome.
